Effect of Gonadotropin-Releasing Hormone Antagonist on the Expression Patterns of Insulin-Like Growth Factor 1, Androgen Receptor, and Luteinizing Hormone Receptor in an Experimental Rat Model of Functional Ovarian Cysts
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Gonadotropin-releasing hormone antagonist (ant-GnRH) treatment positively impacts ovarian function by altering insulin-like growth factor 1, androgen receptor, and luteinizing hormone receptor expression, effectively reducing functional ovarian cysts.
Area Of Science
- Reproductive Endocrinology
- Ovarian Physiology
Background
- Functional ovarian cysts are a common gynecological issue.
- Intra-ovarian growth factors and hormone receptors play crucial roles in ovarian function.
Purpose Of The Study
- To investigate the effects of gonadotropin-releasing hormone antagonist (ant-GnRH) on ovarian expression of insulin-like growth factor 1 (IGF-1), androgen receptor (AR), and luteinizing hormone receptor (LHR) in a rat model of functional ovarian cysts.
- To assess the therapeutic efficacy of ant-GnRH in managing functional ovarian cysts.
Main Methods
- Modeling functional ovarian cysts in rat ovaries.
- Treatment of modeled cysts with ant-GnRH.
- Analysis of IGF-1, AR, and LHR expression intensity in ovarian tissues, preantral follicles, and cyst epithelial lining.
Main Results
- Simulation of ovarian cysts and ant-GnRH treatment altered IGF-1, LHR, and AR expression levels.
- Expression levels of these markers correlated with the number of growing follicles and cysts.
- Ant-GnRH treatment led to a divergence in LHR and AR expression indices and a significant reduction in cystic cavities.
Conclusions
- Ant-GnRH demonstrates a positive influence on intra-ovarian regulatory factors.
- Ant-GnRH exhibits a therapeutic effect in the management of functional ovarian cysts.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...